Top Markets
#1 QuantixAI QuantixAI +102.23%
#2 龙虾 (Lobster) 龙虾 (Lobster) +29.81%
#3 MetaDAO MetaDAO +26.72%
#4 Pons Pons +25.79%
#5 DOG•GO•TO•THE•MOON (Runes) DOG•GO•TO•THE•MOON (Runes) +25.77%
#6 Rain Rain +25.75%
#7 Bedrock Bedrock +20.69%
#8 Wrapped STX (Velar) Wrapped STX (Velar) +19.32%
#9 Prom Prom +18.01%
#10 Ontology Gas Ontology Gas +17.84%
Coin of the day
QuantixAI QuantixAI
Impostazioni
Lingua
ITALIANO
Valuta
USD
Tema
Immunovant, Inc. Immunovant, Inc.

Immunovant, Inc.

IMVT
Classifica tra le azioni #2340
Immunovant, Inc. is a biopharmaceutical firm in the clinical development phase,... Immunovant, Inc. is a biopharmaceutical firm in the clinical development phase, dedicated to advancing novel monoclonal antibody therapies for the treatment of various autoimmune conditions. The company's primary focus is batoclimab, a pioneering, fully human monoclonal antibody. This antibody is engineered to specifically target and block the neonatal fragment crystallizable receptor (FcRn), a key mechanism in certain autoimmune diseases. Batoclimab is currently undergoing Phase IIa clinical evaluations for treating both myasthenia gravis and thyroid eye disease. Additionally, it has commenced Phase II clinical studies for patients suffering from warm autoimmune hemolytic anemia. Established in 2018, Immunovant operates from its headquarters in New York, New York, functioning as a subsidiary under the umbrella of Roivant Sciences Ltd.
Prezzo delle azioni
$43.42
Capitalizzazione di mercato
$8.96B
Variazione (1 giorno)
0.23%
Variazione (1 anno)
191.61%
Paese
US
Scambia Immunovant, Inc. (IMVT)

Categoria

Healthcare
Storico del prezzo dell'azione per Immunovant, Inc. (IMVT)
Prezzo di chiusura più alto: $42.51 il 2026-08-01

Prezzo di chiusura più basso: $9.88 il 2019-06-01
Storico del prezzo dell'azione di Immunovant, Inc. dal 2019 al 2026
Andamento annuale del prezzo dell'azione
Anno Performance
2026 (TTM) 8.62%
2025 -7.38%
2024 -34.45%
2023 163.89%
2022 99.44%
2021 -84.02%
2020 273.47%
2019 0.00%
Prezzo dell'azione per aziende simili o concorrenti
Azienda Prezzo dell'azione Variazione 1a% Il paese
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $553.23 42.24%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $1.02K 50.35%
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $157.70 522.09%
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $122.47 -12.71%
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $772.27 8.67%
CH